RGTA® technology’s breakthrough potential is supported
by more than 100 preclinical and clinical publications

liseret1
liseret2

Publications, articles and news on RGTA® are sorted by therapeutic domain.

All
Graft
Neurology
Musculoskeletal and Locomotor
Imaging
Cardiovascular
Gastro-Intestinal
Dermatology
Ophtalmology
Other
Oncology
Stem Cells
Dental and Oral
Urology and Gynecology
RGTA technology
CACICOL
CACIPLIQ20

CACICOL® RCT

Equitend® RCT

Equitend® RCT

CACIPLIQ20® – Ischemic wound

CACIPLIQ20® – Chronic wound

CACIPLIQ20® – Post radiation

CACIPLIQ20® – Diabetic Foot Ulcer

CACIPLIQ20® – Foot Ulcer

CACIPLIQ20® – Hand Injury

CACICOL® – Sjögren

liseret1
liseret2
Home
Home

© 2020 – OTR3 – All rights reserved
Design + Development by Popcorn 66

ADDRESS

4, rue Française
75001 Paris, France

© 2020 – OTR3 – All rights reserved
Design + Development by Popcorn 66